The former director of Sydney financial planning practice Hillross Bella Vista has been conditionally released without a conviction recorded after pleading guilty to falsifying documents uncovered during an investigation by the Australian Securities and Investments Commission.
Mining company TerraCom has asked a court to rule on the privilege status of a report by PriceWaterhouseCoopers, produced in reponse to “serious allegations” by a former employee over the falsification of coal quality results.
The judge overseeing class actions against Commonwealth Bank over its money laundering compliance failures has threatened to force the parties to go to trial by a certain date if they can’t agree to “sensible” time limits to ready the case for hearing, noting he would reach retirement age in 2024.
The Office of the Australian Information Commissioner is investigating whether Optus breached privacy law after the telco wrongly published customers’ personal details in the White Pages in 2019.
Sydney’s ongoing COVID-19 lockdown has created “logistical” difficulties delaying the release of a long awaited judgment in the ACCC’s consumer law case against collapsed private college Phoenix Institute, which was accused of misleading students through the marketing of its courses.
Six of Australia’s biggest financial services firms have paid or offered to pay a total of $1.86 billion to customers who were wrongly charged fees for no service or were given bad advice.
A controversial announcement by Victorian-based fruit and vegetable processor SPC that it will mandate COVID-19 vaccines for all of its 450 onsite workers could face legal challenges on several grounds.
A New Zealand-based association representing manuka honey beekeepers has lost its opposition to an application for the ‘Australian Manuka’ trade mark by a Byron Bay honey producer, with IP Australia finding the word ‘manuka’ did not specifically refer to honey made in NZ.
Food and beverage manufacturer Freedom Foods will call its CEO and ex-group chairman to the stand in a case filed by the firm’s former group general counsel, who has dropped her lawyer and is now self-represented.
The Australian Securities and Investments Commission has filed court action against a multi-million dollar Western Australian biotech company, alleging it made several misleading representations to the market during the height of the COVID-19 pandemic.